Pituitary adenomas result in clinical sequelae and accelerated mortality due to central mass
effects or pituitary hormone hypersecretion and/or insufficiency. The low annual incidence …

Background: Although low-and middle-income countries (LMIC) bear the burden of the
pituitary adenomas, most research is conducted in developed countries. However, there has …

Pituitary adenomas are tumors that arise in the anterior pituitary gland. They are the third
most common cause of central nervous system (CNS) tumors among adults. Most adenomas …

Pituitary adenohypophyseal tumors are considered as benign and termed “adenomas”.
However, many tumors are invasive and a proportion of these exhibit an “aggressive …

Detailed analysis of cytodifferentiation and hormone production has classified pituitary
neuroendocrine tumors (PitNETs) in a formal system that reflects the lineage differentiation …

Pituitary adenomas are common benign monoclonal neoplasms accounting for about 15%
of intracranial neoplasms. Data from postmortem studies and imaging studies suggest that 1 …

Context Although most sellar lesions are related to pituitary adenomas, the region gives rise
to a variety of neoplasms that can be associated with substantial morbidity and/or mortality …

Pituitary adenomas are common neuroendocrine neoplasms arising from adenohypophysial
cells. Recent progress in our understanding of pituitary tumorigenesis as well as pathways …

Pituitary adenomas comprise a heterogenous group of adenohypophyseal tumours with
distinct clinicopathological features across both the clinically functioning and silent groups …

Pituitary tumours, the most frequent intracranial tumour, are historically considered benign.
However, various pieces of clinical evidence and recent advances in pathological and …